FDA Has Taken Cautious Approach With Mifepristone, Review Suggests

(MedPage Today) — The FDA has taken a cautious, science-based approach to regulating mifepristone (Mifeprex) over the years, contrary to what the Trump administration has claimed, according to an analysis of agency documents. In a qualitative way…